Literature DB >> 24997735

Breast cancer stem cells and the immune system: promotion, evasion and therapy.

Sarah T Boyle1, Marina Kochetkova.   

Abstract

Cancer stem cells are believed to be a subset of heterogeneous tumour cells responsible for tumour initiation, growth, local invasion, and metastasis. In breast cancer, numerous factors have been implicated in regulation of cancer stem cells, but there is still a paucity of information regarding precise molecular and cellular mechanisms guiding their pathobiology. Components of both the adaptive and the innate immune system have been shown to play a crucial role in supporting breast cancer growth and spread, and recently some immune mediators, both molecules and cells, have been reported to influence breast cancer stem cell biology. This review summarises a small, pioneering body of evidence for the potentially important function of the "immuniche" in maintaining and supporting breast cancer stem cells.

Entities:  

Mesh:

Year:  2014        PMID: 24997735     DOI: 10.1007/s10911-014-9323-y

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  95 in total

Review 1.  The chemokine system and cancer.

Authors:  Frances R Balkwill
Journal:  J Pathol       Date:  2011-11-23       Impact factor: 7.996

2.  CCR5 antagonist blocks metastasis of basal breast cancer cells.

Authors:  Marco Velasco-Velázquez; Xuanmao Jiao; Marisol De La Fuente; Timothy G Pestell; Adam Ertel; Michael P Lisanti; Richard G Pestell
Journal:  Cancer Res       Date:  2012-05-25       Impact factor: 12.701

3.  Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.

Authors:  Daniel Schramek; Andreas Leibbrandt; Verena Sigl; Lukas Kenner; John A Pospisilik; Heather J Lee; Reiko Hanada; Purna A Joshi; Antonios Aliprantis; Laurie Glimcher; Manolis Pasparakis; Rama Khokha; Christopher J Ormandy; Martin Widschwendter; Georg Schett; Josef M Penninger
Journal:  Nature       Date:  2010-09-29       Impact factor: 49.962

4.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

5.  T cells sensitized with breast tumor progenitor cell vaccine have therapeutic activity against spontaneous HER2/neu tumors.

Authors:  Li-Xin Wang; Gregory E Plautz
Journal:  Breast Cancer Res Treat       Date:  2011-12-16       Impact factor: 4.872

6.  Immunoediting of cancers may lead to epithelial to mesenchymal transition.

Authors:  Keith L Knutson; Hailing Lu; Brad Stone; Jennifer M Reiman; Marshall D Behrens; Christine M Prosperi; Ekram A Gad; Arianna Smorlesi; Mary L Disis
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

7.  CXCR4 regulates growth of both primary and metastatic breast cancer.

Authors:  Matthew C P Smith; Kathryn E Luker; Joel R Garbow; Julie L Prior; Erin Jackson; David Piwnica-Worms; Gary D Luker
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

8.  Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.

Authors:  R M Dwyer; S M Potter-Beirne; K A Harrington; A J Lowery; E Hennessy; J M Murphy; F P Barry; T O'Brien; M J Kerin
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

9.  A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells.

Authors:  Yan Zhang; Dandan Lv; Ha-Jeong Kim; Robert A Kurt; Wen Bu; Yi Li; Xiaojing Ma
Journal:  Cell Res       Date:  2012-12-25       Impact factor: 25.617

10.  Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells.

Authors:  Teizo Yoshimura; O M Zack Howard; Toshihiro Ito; Masaki Kuwabara; Akihiro Matsukawa; Keqiang Chen; Ying Liu; Mingyong Liu; Joost J Oppenheim; Ji Ming Wang
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

View more
  11 in total

1.  Association between inflammation and cancer stem cell phenotype in breast cancer.

Authors:  Young Ju Jeong; Hoon Kyu Oh; Sung Hwan Park; Jin Gu Bong
Journal:  Oncol Lett       Date:  2017-12-13       Impact factor: 2.967

Review 2.  Exosomes Derived from Breast Cancer Cells, Small Trojan Horses?

Authors:  Alejandro Villagrasa; Pablo Juan Álvarez; Antonio Osuna; Jose Manuel Garrido; Antonia Aránega; Fernando Rodríguez-Serrano
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-07-01       Impact factor: 2.673

3.  Quantitative investigation of MDA-MB-231 breast cancer cell motility: dependence on epidermal growth factor concentration and its gradient.

Authors:  Tanzila Islam; Haluk Resat
Journal:  Mol Biosyst       Date:  2017-09-26

4.  Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.

Authors:  Mary C Schroeder; Priya Rastogi; Charles E Geyer; Lance D Miller; Alexandra Thomas
Journal:  Oncologist       Date:  2018-01-12

5.  The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages.

Authors:  Sarah T Boyle; Jessica W Faulkner; Shaun R McColl; Marina Kochetkova
Journal:  Mol Cancer       Date:  2015-06-06       Impact factor: 27.401

6.  A pan-cancer modular regulatory network analysis to identify common and cancer-specific network components.

Authors:  Sara A Knaack; Alireza Fotuhi Siahpirani; Sushmita Roy
Journal:  Cancer Inform       Date:  2014-10-28

7.  Impact of CD44 expression on radiation response for bladder cancer.

Authors:  Chun-Te Wu; Wei-Yu Lin; Ying-Hsu Chang; Wen-Cheng Chen; Miao-Fen Chen
Journal:  J Cancer       Date:  2017-04-09       Impact factor: 4.207

Review 8.  Mechanism of immune evasion in breast cancer.

Authors:  Mozhi Wang; Changwang Zhang; Yongxi Song; Zhenning Wang; Yaojia Wang; Fang Luo; Yujie Xu; Yi Zhao; Zhonghua Wu; Yingying Xu
Journal:  Onco Targets Ther       Date:  2017-03-14       Impact factor: 4.147

9.  Expression of chemerin correlates with a poor prognosis in female breast cancer patients.

Authors:  Ghada El-Sagheer; Mariana Gayyed; Asmaa Ahmad; Aliaa Abd El-Fattah; Manar Mohamed
Journal:  Breast Cancer (Dove Med Press)       Date:  2018-10-23

Review 10.  More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer.

Authors:  Kerry B Goralski; Ashley E Jackson; Brendan T McKeown; Christopher J Sinal
Journal:  Int J Mol Sci       Date:  2019-09-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.